iShares U.S. Pharmaceuticals ETF (IHE) is highlighted for having a lower expense ratio and a substantially higher dividend yield than the iShares Biotechnology ETF (IBB), making IHE more attractive on an income-and-cost basis.
iShares U.S. Pharmaceuticals ETF (IHE) is highlighted for having a lower expense ratio and a substantially higher dividend yield than the iShares Biotechnology ETF (IBB), making IHE more attractive on an income-and-cost basis.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.10
